Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.
Universe Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Universe Pharmaceuticals Inc 주요 수익원은 Traditional Chinese Medicine Derivatives이며, 최신 수익 발표에서 수익은 32,308,735입니다. 지역별로는 China이 Universe Pharmaceuticals Inc의 주요 시장이며, 수익은 32,308,735입니다.
Universe Pharmaceuticals Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Universe Pharmaceuticals Inc의 순손실은 $0입니다.